Vertex Pharmaceuticals, Inc. has announced interim results from an ongoing study of the experimental drug VX-809, used in conjunction with... Read More
Tomorrow marks the highly anticipated release of our fourth annual Trademark Intelligence Report, offering a comprehensive analysis of the trademark... Read More
Tomorrow marks the highly anticipated release of our fourth annual Trademark Intelligence Report, offering a comprehensive analysis of the trademark... Read More
Tomorrow marks the highly anticipated release of our fourth annual Trademark Intelligence Report, offering a comprehensive analysis of the trademark... Read More